Devices descending from DEN200072
10 later devices reach Lumipulse G ß-Amyloid Ratio (1-42/1-40) through their predicates, nearest generation first.
| Generation | Number | Device | Applicant | Decided | Own descendants | Recalls |
|---|---|---|---|---|---|---|
| +1 | K253240 | PrecivityAD2 Test | C2N Diagnostics, LLC | 2026 | 0 | — |
| +1 | K242706 | Lumipulse G pTau217/ß-Amyloid 1-42 Plasma Ratio | Fujirebio Diagnostics,Inc. | 2025 | 1 | 7 |
| +1 | K233472 | CVAC Aspiration System + CVAC Image Processor | Calyxo, Inc. | 2024 | 3 | Class I |
| +1 | K221842 | Elecsys B-Amyloid (1-42) CSF II, Elecsys Phospho-Tau (181P) CSF | Roche Diagnostics | 2022 | 2 | — |
| +2 | K261447 | CVAC® Aspiration System | Calyxo, Inc. | 2026 | 0 | — |
| +2 | K261686 | Elecsys Phospho-Tau (217P) Plasma | Roche Diagnostics | 2026 | 0 | — |
| +2 | K260965 | CVAC Aspiration System | Calyxo, Inc. | 2026 | 0 | — |
| +2 | K260013 | CVAC Image Processor | Calyxo, Inc. | 2026 | 0 | — |
| +2 | K252163 | Elecsys Phospho-Tau (181P) Plasma | Roche Diagnostics | 2025 | 0 | — |
| +2 | K231348 | Elecsys ß-Amyloid (1-42) CSF II, Elecsys Total-Tau CSF | Roche Diagnostics | 2023 | 0 | — |